Dataset: 11.1K articles from the COVID-19 Open Research Dataset (PMC Open Access subset)
All articles are made available under a Creative Commons or similar license. Specific licensing information for individual articles can be found in the PMC source and CORD-19 metadata
.
More datasets: Wikipedia | CORD-19

Logo Beuth University of Applied Sciences Berlin

Made by DATEXIS (Data Science and Text-based Information Systems) at Beuth University of Applied Sciences Berlin

Deep Learning Technology: Sebastian Arnold, Betty van Aken, Paul Grundmann, Felix A. Gers and Alexander Löser. Learning Contextualized Document Representations for Healthcare Answer Retrieval. The Web Conference 2020 (WWW'20)

Funded by The Federal Ministry for Economic Affairs and Energy; Grant: 01MD19013D, Smart-MD Project, Digital Technologies

Imprint / Contact

Results for Query ‹ H1N1 Flu medication

Difference in immune response in vaccinated and unvaccinated Swedish individuals after the 2009 influenza pandemic – Pre-publication history

Influenza A Virus Entry Inhibitors Targeting the Hemagglutinin – 7. Conclusions

Influenza A Virus Entry Inhibitors Targeting the Hemagglutinin – 6. HA-Targeting Natural Products

Self-reported adverse reactions in 4337 healthcare workers immunizations against novel H1N1 influenza – Discussion

Why do I need it? I am not at risk! Public perceptions towards the pandemic (H1N1) 2009 vaccine – Pre-publication history

Self-reported adverse reactions in 4337 healthcare workers immunizations against novel H1N1 influenza – Duration of symptoms

Difference in immune response in vaccinated and unvaccinated Swedish individuals after the 2009 influenza pandemic – Authors’ contributions

Pains and Gains from China's Experiences with Emerging Epidemics: From SARS to H7N9 – 4. Scientific and Technological Progress

Respiratory viral pathogens among Singapore military servicemen 2009 – 2012: epidemiology and clinical characteristics – Pre-publication history

Current Approaches for Diagnosis of Influenza Virus Infections in Humans – 4.4. Complement Fixation

Challenges and Strategies of Laboratory Diagnosis for Newly Emerging Influenza Viruses in Taiwan: A Decade after SARS – 5. Emergence of Novel Pandemic Influenza Viruses

Evaluation of custom multiplex real - time RT - PCR in comparison to fast - track diagnostics respiratory 21 pathogens kit for detection of multiple respiratory viruses – Conclusion

Clinical features of children hospitalized with influenza A and B infections during the 2012–2013 influenza season in Italy – Conclusions

Etiology and Clinical Characteristics of Influenza-Like Illness (ILI) in Outpatients in Beijing, June 2010 to May 2011 – Ethics statement

Pains and Gains from China's Experiences with Emerging Epidemics: From SARS to H7N9 – 3. Sustaining Government Administration Reforms

Current Approaches for Diagnosis of Influenza Virus Infections in Humans – 1. Introduction

Epidemiology and prevention of influenza in children in Argentina and Brazil – CHALLENGES IN INFLUENZA PREVENTION IN ARGENTINA AND BRAZIL

Epidemiology and prevention of influenza in children in Argentina and Brazil – Surveillance strategies

Molecular diagnosis of microbial copathogens with influenza A(H1N1)pdm09 in Oaxaca, Mexico – Inclusion

Self-reported anticipated compliance with physician advice to stay home during pandemic (H1N1) 2009: Results from the 2009 Queensland Social Survey – Pre-publication history

The pig as a mixing vessel for influenza viruses: Human and veterinary implications – The ecology of influenza A viruses

Challenges and Strategies of Laboratory Diagnosis for Newly Emerging Influenza Viruses in Taiwan: A Decade after SARS – 4. Development of Laboratory Diagnostic Systems for Influenza

Molecular diagnosis of microbial copathogens with influenza A(H1N1)pdm09 in Oaxaca, Mexico – Introduction

Pandemic 2009 H1N1 virus infection in children and adults: A cohort study at a single hospital throughout the epidemic – Statistical analysis

Why do I need it? I am not at risk! Public perceptions towards the pandemic (H1N1) 2009 vaccine – Competing interests